NCT06048926 2023-09-21
Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase NA Enrolling by invitation
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital of Soochow University
Alliance for Clinical Trials in Oncology